Degenerative hip disease Osteoarthritis
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients who have received an uncemented 'ceramics-on-ceramics' Total Hip Arthroplasty in the ErasmusMC during the years 2000 up to and including 2010.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main endpoint of the study is the survival of the prosthesis. The prosthesis survival is otherwise described as the time between the day of the primary THA procedure and the day revision surgery is performed, measured in months. | — |
Secondary
| Measure | Time frame |
|---|---|
| -Radiographic signs of osteolysis in three acetabular zones according to De Lee and Charnley, and in seven femoral zones according to Gruen, signs of stress-shielding (loss of trabecular density and decreasing cortical index), prosthetic migration, fractures. -Analysis of the reason for prosthetic failure -Heterotopic ossification according to Brookers classification (I-IV) -Radiographic analysis of implant positioning on AP and axial images -Clinical performance and functional outcomes using the Harrison Hip Score (HHS), patient satisfaction in Visual Analogue Scale (VAS), the anamnestic incidence of mid thigh pain and groin pain, static and dynamic (2008 Luca et al.), pain severity during the entire period of follow-up (VAS), squeaking. -Physical impairments of the hip: gait analysis, Trendelenburg*s sign, strength and stability, range of motion and leg length. | — |
Countries
Netherlands
Outcome results
None listed